Net gamma exposure for Annovis Bio Inc (ANVS) options was positive at the Nov 4, 2026 close, about $15.94K per 1% move in the stock. It has been positive on 20 of the last 20 trading days. With positive gamma, dealer hedging tends to lean against price moves, which can dampen swings.
Upgrade to unlock Gamma Flip, Gamma Profile, Call Wall, Put Wall, and multiple expiration dates.
Gamma Exposure by Strike
Showing results for ANVS, 2026-11-06(w), calls & puts
Gamma Exposure Stats
Showing results for ANVS, 2026-11-06(w), calls & puts
Net Gamma Exposure by Expiration
Showing results for ANVS, 2026-11-06(w), calls & puts. View all expiries
| Expiration | Net GEX | Call GEX | Put GEX | Call Wall | Put Wall | Gamma Flip |
|---|
ANVS Gamma Exposure FAQ
What is gamma exposure (GEX)?
Gamma exposure estimates how much stock option dealers must buy or sell to stay hedged for each 1% move in the underlying.
Is ANVS gamma exposure positive or negative?
Annovis Bio net gamma exposure was positive on Nov 4, 2026, at $15.94K. It has been positive on 20 of the last 20 trading days.
How has ANVS gamma exposure changed recently?
Annovis Bio net gamma exposure went from $13.87K on Oct 7, 2026 to $15.94K on Nov 4, 2026. See the ANVS gamma exposure history for a longer view.
What is Annovis Bio Inc?
Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States.